Outsourced Pharma

Outsourced Pharma
Share

Outsourced Pharma

 •  September 20

CordenPharma, a contract development and manufacturing organization of drug substances and drug products, has completed an early-development suite for highly potent, oral solid dosage products at its site in Plankstadt, Germany. The new facility allows for the production of small batches, from 100 g to approximately 1,000 g. CordenPharma...

Outsourced Pharma

 •  September 19

Ajinomoto Althea, Inc. (“Althea”), a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it will soon open a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility located in San Diego, CA. Althea took ownership of the new facility on May 1st,...

Outsourced Pharma

 •  September 18

Cambridge, MA /PRNewswire/ - Brammer Bio ("Brammer"), a cell and gene therapy contract development and manufacturing organization (CDMO), today announced completion of its clinical capacity expansion in Alachua, Florida. This doubles Brammer's early phase manufacturing capacity to support clients' Phase I/II cell and gene therapy clinical...

Outsourced Pharma

 •  September 12

SERAING, BELGIUM--(BUSINESS WIRE)-- Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced today that its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter. The expansion will allow for...

Outsourced Pharma

 •  September 7

According to new industry research more than half (54%) of industry professionals believe that the cost of implementing serialization is the greatest hurdle to compliance. The research, conducted by serialization software provider, SEA Vision and life sciences technology firm, Zenith Technologies, highlighted that the substantial investment...

Outsourced Pharma

 •  September 5

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has entered into an exclusive agreement with US WorldMeds, LLC for the commercial manufacture of lofexidine, an investigational drug under development to mitigate...

Outsourced Pharma

 •  August 30

East Rutherford, NJ (GLOBE NEWSWIRE) - Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical laboratory. The investment comes in...

Outsourced Pharma

 •  August 28

Ajinomoto Althea, Inc. (“Althea”), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the installation and launch of a new high-performance sterile vial filling line. The new Optima VFVM 7000 aseptic fill finish line further strengthens Althea’s drug product manufacturing capabilities and...

Outsourced Pharma

 •  August 24

Contact The Supplier Ajinomoto Althea, Inc. (“Althea”), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the installation and launch of a new high-performance sterile vial filling line. The new Optima VFVM 7000 aseptic fill finish line further strengthens Althea’s drug product...

Outsourced Pharma

 •  August 22

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 21 million CHF (€19M) into expanding its GMP manufacturing capabilities at its facility in Switzerland. The investment, which is in response to increased market for spray drying and capsule filling for dry powder inhalers, will provide the contract development...